The nomination of chromium picolinate is based on the potential for
widespread consumer exposure. Marketed as a dietary supplement,
chromium picolinate is heavily promoted as a muscle builder and
weight-loss agent. Industry claims suggest that several million persons
may ingest chromium picolinate tablets; sales of chromium-based
supplements are approximately $100 million a year.
Some researchers suggest that chromium picolinate causes a
significant increase in lean body mass by altering the rate of
internalization of insulin. Other investigators have indicated that
recommended doses of chromium picolinate by other than the oral route
would cause accumulation of chromium in the liver and kidneys, an
unknown risk to the consumer. Scrutiny of the literature on chromium
picolinate reveals contentious discussion between researchers and some
unexpected stakeholders.
A beneficiary of the Dietary Supplement Health and Education
Act of 1994, chromium picolinate can be sold legally without evidence
of safety or efficacy.